Marinus Pharmaceuticals

Marinus cuts 45% of staff after key medicine stumbled in pair of phase 3 trials
Fierce Pharma
Wed, 11/13/24 - 07:29 pm
Marinus Pharmaceuticals
layoffs
Ztalmy
Woes mount for Marinus with investor lawsuit, trial failure
Fierce Pharma
Mon, 06/17/24 - 10:26 pm
Marinus Pharmaceuticals
ganaxolone
legal
clinical trials
refractory status epilepticus
Marinus lays off 20% of staff to steady ship after IV seizure med's phase 3 struggles
Fierce Biotech
Wed, 05/8/24 - 11:14 am
Marinus Pharmaceuticals
layoffs
ganaxolone
Marinus fails to meet early stopping criteria for status epilepticus trial
Clinical Trials Arena
Tue, 04/16/24 - 07:32 am
Marinus Pharmaceuticals
clinical trials
ganaxolone
status epilepticus
Marinus Pharma Shares Up After Deal for Rare Pediatric Disease Priority Review Voucher
Morningstar
Thu, 07/14/22 - 10:49 am
Marinus Pharmaceuticals
priority review vouchers
pediatrics
Novo Nordisk
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
FDA
drug approvals
FibroGen
AstraZeneca
daprodustat
Bristol Myers Squibb
Opdivo
Roche
tiragolumab
Merck
favezelima
bInnovent
Eli Lilly
Akeso Biopharma
Sino Biopharmaceutical
Novartis
Ukoniq
TG Therapeutics
GW Pharmaceuticals
Marinus Pharmaceuticals